Answers are grounded in this paper and cite their sources.
Ketone monoester (KME) ingestion lowers cerebral blood flow (CBF), likely due to reduced arterial carbon dioxide (P a CO 2 ). We tested the hypothesis that maintaining end-tidal CO 2 (P ET CO 2 ; surrogate for P a CO 2 ) following KME ingestion would prevent reductions in CBF and improve cerebrovascular reactivity (CVR) to CO 2 compared to free-breathing. In a single-blinded randomized crossover design, twenty-three adults (age=22±2 yrs) ingested 0.6 g·kg -1 KME and breathed either room air (poikilocapnia) or a gas mixture that clamped P ET CO 2 at baseline (isocapnia) for 60 min. CVR to CO 2 was assessed at targeted P ET CO 2 of +3, +6, and +9 mmHg above baseline. CBF was assessed using duplex ultrasound of extracranial arteries and transcranial Doppler ultrasound of the middle cerebral artery. Venous β-hydroxybutyrate, pH, and bicarbonate were measured. Outcomes were assessed at baseline, 45-, and 60-min post-supplementation. P ET CO 2 was higher during isocapnia at 45 min (3.9±3.8 mmHg; P<0.001) and 60 min (4.4±3.8 mmHg; P<0.001) post-supplementation corresponding with 15% higher CBF compared to poikilocapnia ( P<0.001). Blood pH was reduced during isocapnia ( P<0.001), whereas it was unchanged in poikilocapnia ( P=0.246), suggesting that the ventilatory response to KME ingestion effectively buffered metabolic acidosis in poikilocapnia. CVR to CO 2 was reduced following KME ingestion regardless of condition ( P<0.001). Exploratory analyses demonstrated that biological sex did not alter cerebrovascular responses to KME ingestion. This work confirms that reductions in CBF and CVR to CO 2 following KME ingestion are due to reduced P a CO 2 in response to metabolic acidosis. Strategies that buffer metabolic acidosis likely will mitigate CBF reductions following acute KME ingestion.
No takes yet. Share an insight, caveat, or question.
Yong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: